Tags

Type your tag names separated by a space and hit enter

Recognizing and managing patients with irritable bowel syndrome.
J Am Acad Nurse Pract 2005; 17(2):51-9JA

Abstract

PURPOSE

To address the diagnosis and clinical management of irritable bowel syndrome (IBS) and provide a discussion of the available serotonergic agents.

DATA SOURCES

Recent studies examining the pathophysiology of IBS.

CONCLUSIONS

Diagnostic testing may be required in the subset of patients with IBS who present with alarm symptoms, or "red flags," suggestive of underlying organic disease. An important role has been suggested for the neurotransmitter serotonin in both gut motility and visceral pain sensitivity.

IMPLICATIONS FOR PRACTICE

A diagnosis of IBS is largely based on symptoms; therefore, effective clinician-patient communication and careful attention to details of patient presentation, history, and physical examination are essential.

Authors+Show Affiliations

Seattle Gastroenterology Associates, Seattle, Washington, USA. acroghan@u.washington.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15715899

Citation

Croghan, Anne, and Margaret M. Heitkemper. "Recognizing and Managing Patients With Irritable Bowel Syndrome." Journal of the American Academy of Nurse Practitioners, vol. 17, no. 2, 2005, pp. 51-9.
Croghan A, Heitkemper MM. Recognizing and managing patients with irritable bowel syndrome. J Am Acad Nurse Pract. 2005;17(2):51-9.
Croghan, A., & Heitkemper, M. M. (2005). Recognizing and managing patients with irritable bowel syndrome. Journal of the American Academy of Nurse Practitioners, 17(2), pp. 51-9.
Croghan A, Heitkemper MM. Recognizing and Managing Patients With Irritable Bowel Syndrome. J Am Acad Nurse Pract. 2005;17(2):51-9. PubMed PMID: 15715899.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Recognizing and managing patients with irritable bowel syndrome. AU - Croghan,Anne, AU - Heitkemper,Margaret M, PY - 2005/2/18/pubmed PY - 2005/6/23/medline PY - 2005/2/18/entrez SP - 51 EP - 9 JF - Journal of the American Academy of Nurse Practitioners JO - J Am Acad Nurse Pract VL - 17 IS - 2 N2 - PURPOSE: To address the diagnosis and clinical management of irritable bowel syndrome (IBS) and provide a discussion of the available serotonergic agents. DATA SOURCES: Recent studies examining the pathophysiology of IBS. CONCLUSIONS: Diagnostic testing may be required in the subset of patients with IBS who present with alarm symptoms, or "red flags," suggestive of underlying organic disease. An important role has been suggested for the neurotransmitter serotonin in both gut motility and visceral pain sensitivity. IMPLICATIONS FOR PRACTICE: A diagnosis of IBS is largely based on symptoms; therefore, effective clinician-patient communication and careful attention to details of patient presentation, history, and physical examination are essential. SN - 1041-2972 UR - https://www.unboundmedicine.com/medline/citation/15715899/Recognizing_and_managing_patients_with_irritable_bowel_syndrome_ L2 - https://doi.org/10.111/j.1041-2972.2005.0011.x DB - PRIME DP - Unbound Medicine ER -